查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591894

人体肝臟模型市场：按产品和应用分類的全球预测 - 2025-2030

Human Liver Model Market by Product (2D Models, 3D Bio Printing, Liver Organoids), Application (Drug Discovery, Education) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年人类肝臟模型市值为22.6亿美元，预计到2024年将达到25.3亿美元，复合年增长率为12.06%，到2030年将达到50.3亿美元。

人体肝臟模型市场包括开发和利用模拟肝功能用于研究和治疗目的的体外和体内模型。这些模型对于药物发现、临床前测试和毒理学研究至关重要，因为它们可以模拟人类肝臟反应，并可以减少对动物实验的依赖。肝臟疾病盛行率的上升，特别是由于消费量、肥胖和病毒感染的增加，推动了对人类肝臟模型的需求。此外，製药和生物技术行业大量使用这些模型来加速药物开发流程并评估肝毒性风险。最终用途包括製药、生物技术公司和医疗保健部门，研究人员包括学术研究、临床试验和再生医学。

主要市场统计
基准年[2023] 22.6亿美元
预测年份 [2024] 25.3亿美元
预测年份 [2030] 50.3亿美元
复合年增长率（%） 12.06%

市场成长主要受到生物技术进步的影响，例如 3D 生物列印和晶片器官技术，这些技术提供了更准确和功能性的肝臟模型。此外，随着越来越多地采用人类肝臟模型，减少动物试验的监管支持也不断增加。个人化医疗和精准医疗保健的扩展存在潜在的商机，肝臟模型可以提供量身定制的治疗测试。公司应该专注于提高这些模型的生理有效性，并投资于提高可扩展性和可重复性的技术。

儘管具有潜力，但人类肝臟模型市场面临初始投资成本高、模型准确性方面的技术挑战以及体外捕获所有肝功能的复杂性等限制。此外，智慧财产权和严格的监管标准可能对进入和创新构成重大障碍。为了刺激业务成长，研究应着重于改善组织培养和整合人工智慧进行预测分析。与监管机构的持续合作以及对跨学科研究的投资可以进一步放大市场潜力。儘管市场竞争激烈，但提高模型可靠性和适用性的创新时机已经成熟，为拥有尖端解决方案的新进业者提供了沃土。

市场动态：快速发展的人类肝臟模型市场的关键市场洞察

人类肝臟模型市场正在因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 非酒精性脂肪肝盛行率上升
    • 人类肝臟疾病体外建模的新兴 3D 和 2D 趋势
    • 对肝臟类器官的努力和不断提高的认识
  • 市场限制因素
    • 缺乏熟练且训练有素的专业人员
  • 市场机会
    • 对药物发现活动的日益关注
    • 亚太和拉丁美洲的医疗保健成长潜力
  • 市场挑战
    • 创建复杂的人体类器官模型

波特五力战略工具引领人类肝臟模型市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解人类肝臟模型市场的外部影响

外部宏观环境因素在塑造人类肝臟模型市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解人体肝臟模型市场的竞争状况

对人类肝臟模型市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵人体肝臟模型市场供应商绩效评估

FPNV定位矩阵是评估人体肝臟模型市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了人类肝臟模型市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对人类肝臟模型市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 非酒精性脂肪肝盛行率上升
      • 人类肝臟疾病体外建模的新兴 3D 和 2D 趋势
      • 对肝臟类器官的努力和不断提高的认识
    • 抑制因素
      • 缺乏熟练且训练有素的专业人员
    • 机会
      • 增加对药物发现活动的关注
      • 亚太和拉丁美洲的医疗保健成长潜力
    • 任务
      • 生成复杂的人体类器官模型
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章人类肝臟模型市场：副产品

  • 2D模型
  • 3D生物列印
  • 肝臟类器官

第七章人类肝臟模型市场：依应用分类

  • 药物发现
  • 教育

第八章北美与南美人体肝臟模型市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区人体肝臟模型市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲人体肝臟模型市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • BioIVT LLC
  • Biopredic International
  • Cellink Global
  • CN Bio Innovations Ltd.
  • Emulate Inc.
  • InSphero AG
  • MIMETAS BV
  • NeurOmics, Inc.
  • Organovo Holdings Inc.
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • ZenBio, Inc.
Product Code: MRR-43127F7278DC

The Human Liver Model Market was valued at USD 2.26 billion in 2023, expected to reach USD 2.53 billion in 2024, and is projected to grow at a CAGR of 12.06%, to USD 5.03 billion by 2030.

The human liver model market encompasses the development and utilization of in vitro and in vivo models that simulate liver function for research and therapeutic purposes. These models are essential in drug discovery, pre-clinical trials, and toxicological studies due to their capability to mimic human liver responses, thereby reducing dependency on animal testing. The necessity for human liver models is driven by the rising prevalence of liver diseases, notably attributed to increasing alcohol consumption, obesity, and viral infections. Moreover, the pharmaceutical and biotechnology industries heavily employ these models to accelerate drug development pipelines and assess hepatotoxicity risks. Application extends to academic research, clinical trials, and regenerative medicine, with end-use spanning pharmaceutics, biotechnology firms, and healthcare sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 2.26 billion
Estimated Year [2024] USD 2.53 billion
Forecast Year [2030] USD 5.03 billion
CAGR (%) 12.06%

Market growth is primarily influenced by advancements in biotechnology, such as 3D bioprinting and organ-on-a-chip technologies, which offer more accurate and functional liver models. Furthermore, growing regulatory support for reducing animal testing aligns with the increasing adoption of human liver models. Potential opportunities lie in the expansion of personalized medicine and precision healthcare, where liver models could offer bespoke treatment testing. Companies should focus on enhancing the physiological relevance of these models and invest in technologies that improve scalability and reproducibility.

Despite its potential, the human liver model market faces limitations, including high initial investment costs, technical challenges in model accuracy, and the complexity of capturing all liver functions in vitro. Also, intellectual property rights and stringent regulatory standards can pose significant barriers to entry and innovation. To spur business growth, research should concentrate on refining tissue cultures and integrating artificial intelligence for predictive analytics. Continuous collaboration with regulatory bodies and investment in interdisciplinary research can further amplify market potential. The nature of the market is competitive yet ripe for innovations that enhance model reliability and applicability, presenting a fertile ground for new entrants with cutting-edge solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Liver Model Market

The Human Liver Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence rate of non-alcoholic fatty liver disease
    • Emerging 3D and 2D trends in modeling human liver disease in vitro
    • Rising initiatives and awareness about liver organoids
  • Market Restraints
    • Lack of skilled and trained professionals
  • Market Opportunities
    • Growing focus on drug discovery activities
    • Potential growth of healthcare in the Asia Pacific and Latin America
  • Market Challenges
    • Generation of complex human organoid models

Porter's Five Forces: A Strategic Tool for Navigating the Human Liver Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Liver Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Liver Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Liver Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Liver Model Market

A detailed market share analysis in the Human Liver Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Liver Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Liver Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Human Liver Model Market

A strategic analysis of the Human Liver Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Human Liver Model Market, highlighting leading vendors and their innovative profiles. These include BioIVT LLC, Biopredic International, Cellink Global, CN Bio Innovations Ltd., Emulate Inc., InSphero AG, MIMETAS B.V., NeurOmics, Inc., Organovo Holdings Inc., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Human Liver Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across 2D Models, 3D Bio Printing, and Liver Organoids.
  • Based on Application, market is studied across Drug Discovery and Education.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence rate of non-alcoholic fatty liver disease
      • 5.1.1.2. Emerging 3D and 2D trends in modeling human liver disease in vitro
      • 5.1.1.3. Rising initiatives and awareness about liver organoids
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled and trained professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing focus on drug discovery activities
      • 5.1.3.2. Potential growth of healthcare in the Asia Pacific and Latin America
    • 5.1.4. Challenges
      • 5.1.4.1. Generation of complex human organoid models
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Human Liver Model Market, by Product

  • 6.1. Introduction
  • 6.2. 2D Models
  • 6.3. 3D Bio Printing
  • 6.4. Liver Organoids

7. Human Liver Model Market, by Application

  • 7.1. Introduction
  • 7.2. Drug Discovery
  • 7.3. Education

8. Americas Human Liver Model Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Human Liver Model Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Human Liver Model Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BioIVT LLC
  • 2. Biopredic International
  • 3. Cellink Global
  • 4. CN Bio Innovations Ltd.
  • 5. Emulate Inc.
  • 6. InSphero AG
  • 7. MIMETAS B.V.
  • 8. NeurOmics, Inc.
  • 9. Organovo Holdings Inc.
  • 10. STEMCELL Technologies Inc.
  • 11. Thermo Fisher Scientific Inc.
  • 12. ZenBio, Inc.

LIST OF FIGURES

  • FIGURE 1. HUMAN LIVER MODEL MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN LIVER MODEL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN LIVER MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HUMAN LIVER MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HUMAN LIVER MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN LIVER MODEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN LIVER MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN LIVER MODEL MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 2D MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 3D BIO PRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY LIVER ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. HUMAN LIVER MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. HUMAN LIVER MODEL MARKET, FPNV POSITIONING MATRIX, 2023